Jim Wassil - 15 Mar 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
15 Mar 2024
Transactions value $
-$103,435
Form type
4
Filing time
19 Mar 2024, 16:26:44 UTC
Previous filing
04 Mar 2024
Next filing
03 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Award $0 +4.1K +1.87% $0.00 223K 15 Mar 2024 Direct F1
transaction PCVX Common Stock Tax liability -$103K -1.48K -0.67% $69.70 221K 15 Mar 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock underlying restricted stock units ("RSUs") issued in lieu of a cash bonus by election of the Reporting Person, such election available to all of Issuer's senior management. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs are fully vested upon the date of grant.
F2 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.